Prot# EDOAGL-8725-001: A Phase III, Randomized, Open-Label Study of IV Edotecarin vs. Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients w/Glioblastoma Multiforme that has Progressed/Recurred after Alkylator-Based (Neo)Adjuvant Chemotherapy